8-20249712-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_021020.5(LZTS1):c.*10T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000374 in 1,589,626 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0020 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00021 ( 2 hom. )
Consequence
LZTS1
NM_021020.5 3_prime_UTR
NM_021020.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.33
Genes affected
LZTS1 (HGNC:13861): (leucine zipper tumor suppressor 1) This gene encodes a tumor suppressor protein that is ubiquitously expressed in normal tissues. In uveal melanomas, expression of this protein is silenced in rapidly metastasizing and metastatic tumor cells but has normal expression in slowly metastasizing or nonmetastasizing tumor cells. This protein may have a role in cell-cycle control by interacting with the Cdk1/cyclinB1 complex. This gene is located on chromosomal region 8p22. Loss of heterozygosity (LOH) in the 8p arm is a common characteristic of many types of cancer. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 8-20249712-A-T is Benign according to our data. Variant chr8-20249712-A-T is described in ClinVar as [Benign]. Clinvar id is 3052596.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LZTS1 | NM_021020.5 | c.*10T>A | 3_prime_UTR_variant | 4/4 | ENST00000381569.5 | NP_066300.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LZTS1 | ENST00000381569.5 | c.*10T>A | 3_prime_UTR_variant | 4/4 | 5 | NM_021020.5 | ENSP00000370981 | P1 | ||
LZTS1 | ENST00000265801.6 | c.*10T>A | 3_prime_UTR_variant | 3/3 | 1 | ENSP00000265801 | P1 | |||
LZTS1 | ENST00000522290.5 | downstream_gene_variant | 1 | ENSP00000429263 |
Frequencies
GnomAD3 genomes AF: 0.00197 AC: 300AN: 152080Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
300
AN:
152080
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000537 AC: 128AN: 238568Hom.: 1 AF XY: 0.000394 AC XY: 51AN XY: 129406
GnomAD3 exomes
AF:
AC:
128
AN:
238568
Hom.:
AF XY:
AC XY:
51
AN XY:
129406
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000206 AC: 296AN: 1437428Hom.: 2 Cov.: 31 AF XY: 0.000182 AC XY: 130AN XY: 712864
GnomAD4 exome
AF:
AC:
296
AN:
1437428
Hom.:
Cov.:
31
AF XY:
AC XY:
130
AN XY:
712864
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00196 AC: 299AN: 152198Hom.: 3 Cov.: 33 AF XY: 0.00198 AC XY: 147AN XY: 74418
GnomAD4 genome
AF:
AC:
299
AN:
152198
Hom.:
Cov.:
33
AF XY:
AC XY:
147
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
LZTS1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 06, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at